The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder. A randomized, placebo-controlled trial.

Meerkanten GGz0 个研究点开始时间: 2007年4月17日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•-Patients with a primary DSM-IV diagnosis of OCD with an age of 18 years and older as established with the Structural Clinical Interview for axis I DSM-IV Disorders (SCID I)
•-Obsessive-compulsive complaints has to be such that exposure in vivo is feasible at the outpatient department, in the clinic or the direct environment.
•-Patients have to understand the rationale of exposure therapy and there has to be a readiness to participate in exposure sessions.
•-If a patient uses medication, dosages have to be stable (no changes in the last 2 months and during the study period).
•-Negative pregnancy test (ß-HCG in urine).
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•-Addiction to alcohol or drugs or abuse of these compounds
•-A primary diagnosis of a personality disorder
•-Psychotic disorder
•-Relevant somatic disorders
•-Suicidal intentions
•-Pregnancy or breastfeeding
•-Usage of medication possibly interfering with DCS (isoniazide, protonionamide)

发起方

Meerkanten GGz